Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JUN | P05412 | 1/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | TTR | P02766 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.63 |
| ▸ | TUBB | P07437 | 2/20 | 0.63 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.63 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.63 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.63 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.63 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.63 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.63 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4257202 | 1.00 | JUN (0.64) | JUNNFKB1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL4257208 | 1.00 | JUN (0.64) | JUNNFKB1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL4259088 | 0.89 | MAPT (0.63) | JUNNFKB1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL4259090 | 0.89 | MAPT (0.63) | JUNNFKB1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL4255499 | 0.89 | MAPT (0.63) | JUNNFKB1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL15884198 | 0.89 | TUBB4A (0.72) | JUNNFKB1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL8620260 | 0.89 | JUN (0.69) | JUNNFKB1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL4252780 | 0.87 | MEN1 (0.75) | KMT2ASMN1; SMN2MAPTMEN1KDM4E | |
| SCHEMBL4252772 | 0.87 | MEN1 (0.75) | KMT2ASMN1; SMN2MAPTMEN1KDM4E | |
| SCHEMBL4252777 | 0.87 | MEN1 (0.75) | KMT2ASMN1; SMN2MAPTMEN1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9067908-B2 | Polyphenolic bioprecursors | RHODIA CHIMIE (FR) | 2015-06-30 | — | — | US | claimed |
| US-20090215881-A1 | Polyphenolic Bioprecursors | CHIMIE, Rhodia Chime (FR) | 2009-08-27 | — | — | US | claimed |
| EP-1893555-A1 | POLYPHENOL-BASED BIOPRECURSOR | RHODIA CHIMIE (FR) | 2008-03-05 | — | — | EP | claimed |
| WO-2006134282-A1 | POLYPHENOL-BASED BIOPRECURSOR | RHODIA CHIMIE (FR) | 2006-12-21 | — | — | WO | claimed |
| US-9067908-B2 | Polyphenolic bioprecursors | RHODIA CHIMIE (FR) | 2015-06-30 | — | — | US | disclosed |
| EP-1893555-B1 | POLYPHENOL-BASED BIOPRECURSOR | RHODIA CHIMIE SA (FR) | 2014-10-29 | — | — | EP | disclosed |
| US-20090215881-A1 | Polyphenolic Bioprecursors | CHIMIE, Rhodia Chime (FR) | 2009-08-27 | — | — | US | disclosed |
| EP-1893555-A1 | POLYPHENOL-BASED BIOPRECURSOR | RHODIA CHIMIE (FR) | 2008-03-05 | — | — | EP | disclosed |
| WO-2006134282-A1 | POLYPHENOL-BASED BIOPRECURSOR | RHODIA CHIMIE (FR) | 2006-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215881-A1 | Polyphenolic Bioprecursors | PPARG, PPARA, FABP4 | JUN 1057/4885NFKB1 435/4885KMT2A 2120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.